Top Institutions in Ophthalmology - Rare and Rarely Diagnosed Diseases
Institutions were ranked based on their known leadership in ophthalmic rare disease research, clinical trial expertise, translational research in orphan drug development, and contributions to regulatory science and patient education in rare eye disorders.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as the top ophthalmology center in the US, with extensive research programs in rare ocular diseases and a strong clinical trials infrastructure for orphan drug development.
Key Differentiators
- Ophthalmology
- Rare Eye Diseases
- Clinical Trials
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Mass Eye and Ear has a strong focus on genetic and rare eye diseases, with pioneering work in molecular diagnostics and participation in FDA orphan drug trials.
Key Differentiators
- Ophthalmology
- Genetic Eye Diseases
- Rare Disease Research
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its comprehensive approach to rare ophthalmic diseases, combining clinical care, research, and education, including leadership in orphan drug development.
Key Differentiators
- Ophthalmology
- Rare Eye Disorders
- Clinical Research
-
#4
University of California, San Francisco (UCSF) Department of Ophthalmology
San Francisco, CA
UCSF is a leader in translational research for rare genetic eye diseases, with robust programs in gene therapy and orphan drug clinical trials.
Key Differentiators
- Ophthalmology
- Rare Genetic Eye Diseases
- Translational Research
-
#5
Mayo Clinic Department of Ophthalmology
Rochester, MN
Mayo Clinic offers comprehensive clinical care and research in rare ophthalmic diseases, with a focus on patient-centered approaches and clinical trial participation.
Key Differentiators
- Ophthalmology
- Rare Eye Disease Clinical Care
- Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
